Vor Biopharma Inc.
VOR
$23.82
-$1.28-5.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 466.13M | 491.53M | 455.21M | 170.46M | 200.57M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.88M | 6.39M | 1.15M | 747.00K | 1.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.10M | 2.86M | 1.75M | 1.28M | 2.86M |
| Total Current Assets | 475.11M | 500.78M | 458.11M | 172.49M | 204.93M |
|
|
|||||
| Total Current Assets | 475.11M | 500.78M | 458.11M | 172.49M | 204.93M |
| Net Property, Plant & Equipment | 3.37M | 3.39M | 3.47M | 3.31M | 24.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.58M | 2.58M | 2.55M | 437.00K | 420.00K |
| Total Assets | 481.05M | 506.75M | 464.13M | 176.24M | 205.37M |
|
|
|||||
| Total Accounts Payable | 4.00M | 1.04M | 5.13M | 885.00K | 669.00K |
| Total Accrued Expenses | 20.48M | 14.73M | 19.76M | 17.70M | 58.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 335.00K | 307.00K | 280.00K | 252.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 24.81M | 16.08M | 25.17M | 18.84M | 58.77M |
|
|
|||||
| Total Current Liabilities | 24.81M | 16.08M | 25.17M | 18.84M | 58.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.54M | 2.63M | 2.72M | 2.81M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 653.89M | 638.46M | 600.55M | 2.38B | 1.65B |
| Total Liabilities | 681.25M | 657.17M | 628.44M | 2.40B | 1.71B |
|
|
|||||
| Common Stock & APIC | 1.24B | 1.22B | 988.62M | 650.33M | 557.44M |
| Retained Earnings | -1.44B | -1.37B | -1.15B | -2.88B | -2.06B |
| Treasury Stock & Other | -922.00K | -706.00K | 41.00K | 12.00K | 14.00K |
| Total Common Equity | -200.20M | -150.42M | -164.31M | -2.23B | -1.51B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -200.20M | -150.42M | -164.31M | -2.23B | -1.51B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -200.20M | -150.42M | -164.31M | -2.23B | -1.51B |
|
|
|||||